EPIEFFECT is a minimally manipulated, lyophilized, non-viable cellular allograft derived from human amniotic membrane
INTENDED USES: Intended for use as a barrier, to provide a protective environment in acute and chronic wounds.
CLAIMED BENEFITS: Easy to apply. Shelf-stable. 5-year shelf life. Terminally sterilized for additional level of safety.
Compatible with compression therapy, Negative Pressure Wound Therapy (NPWT) and Hyperbaric Oxygen Therapy (HBOT). Contains 300+ regulatory proteins
OPTIONS: Per Square Centimeter
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care